2SEVENTY BIO INC's ticker is and the CUSIP is 901384107. A total of 139 filers reported holding 2SEVENTY BIO INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,522,892 | -61.3% | 1,408,901 | 0.0% | 0.62% | -57.9% |
| Q2 2023 | $14,258,078 | +99114.2% | 1,408,901 | 0.0% | 1.47% | -18.3% |
| Q1 2023 | $14,371 | +8.9% | 1,408,901 | 0.0% | 1.80% | +21.8% |
| Q4 2022 | $13,201 | -99.9% | 1,408,901 | 0.0% | 1.48% | -39.7% |
| Q3 2022 | $20,500,000 | +10.2% | 1,408,901 | 0.0% | 2.45% | +12.2% |
| Q2 2022 | $18,597,000 | -22.6% | 1,408,901 | 0.0% | 2.18% | -6.6% |
| Q1 2022 | $24,036,000 | +422.7% | 1,408,901 | +685.4% | 2.33% | +539.5% |
| Q4 2021 | $4,598,000 | – | 179,393 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,587,805 | $27,088,000 | 6.49% |
| CHI Advisors LLC | 819,672 | $13,984,000 | 5.95% |
| Madison Avenue Partners, LP | 896,972 | $15,302,342,000 | 2.86% |
| Bain Capital Life Sciences Investors, LLC | 1,408,901 | $24,036,000 | 2.33% |
| EcoR1 Capital, LLC | 3,495,943 | $59,641,000 | 1.87% |
| TANG CAPITAL MANAGEMENT LLC | 300,000 | $5,118,000 | 1.02% |
| CVI Holdings, LLC | 819,672 | $13,984,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 2,000,000 | $34,120,000 | 0.66% |
| Altium Capital Management LP | 115,000 | $1,962,000 | 0.66% |
| Casdin Capital, LLC | 614,754 | $10,488,000 | 0.47% |